Portfolio Company · Operating Co.

Nabla Bio

Bio Tools, Medicines

backed byPillar VC

CurrentBio Tools, Medicines

Nabla Bio

a portfolio company of

Pillar VC

Status on record: Current

Investment year: 2020

PE Firm Index

Who owns Nabla Bio?

Nabla Bio is listed as a current portfolio company of Pillar VC on Pillar VC's own portfolio page. Pillar VC has owned Nabla Bio since 2020, per Pillar VC's portfolio page.

Company Snapshot

Nabla Bio is a Bio Tools, Medicines company. Its owner on record, Pillar VC, is a firm. Pillar VC lists at least 78 companies in the index, 13 of them in Bio Tools, Medicines.

SectorBio Tools, Medicines

Parent PE firmPillar VC

Ownership statusCurrent

WebsiteNot on record

About the owner

Pillar VC

Companies in the index: At least 78

Early-stage venture capital firm based in Boston.

Read the Pillar VC profile

Questions about Nabla Bio

Who owns Nabla Bio?

Nabla Bio is listed as a current portfolio company of Pillar VC on Pillar VC's own portfolio page. Pillar VC has owned Nabla Bio since 2020, per Pillar VC's portfolio page.

What sector is Nabla Bio in?

Nabla Bio is in Bio Tools, Medicines. Classified from the owner's portfolio label.

What else does Pillar VC own in Bio Tools, Medicines?

Pillar VC lists 12 other Bio Tools, Medicines companies in the index, including Adaptilens, Amber Bio, Amplifyer Bio, Drosera Bio and Euler Bio.

Sources

Pillar VC
https://www.pillar.vc/companies/

This profile is based on publicly available information and may be incomplete or outdated. PE Firm Index is not affiliated with Nabla Bio and does not provide investment advice.

Other portfolio companies of Pillar VC

6 of 77 shown

Abridge

Advanced Computing, Healthcare

AceLab

Enterprise Intelligence

Decentralized Systems

Amber Bio

Medicines, Synthetic Biology

See the full Pillar VC portfolio.

Other Bio Tools, Medicines companies held by Pillar VC

Adaptilens Amber Bio Amplifyer Bio Drosera Bio

Euler Bio Metri

Other Bio Tools, Medicines portfolio companies

via Wavemaker 360 Health

3P Biopharmaceuticals

via Marlin Equity Partners

Browse PE-backed companies.

Is this your company?

Claiming is free and reviewed by hand. Correct facts and add your team.

Claim this profile Suggest a correction

Ownership

Parent PE firm

Pillar VC

Status: Current

Investment year: 2020

For PE-backed companies

DevriX

DevriX runs the websites, integrations and data that bring in revenue, as one accountable engineering and operations team, through acquisitions and exit.

Where DevriX helps

Value creation through the holdRevenue, data, web and AI run as one operating cadence, tied to EBITDA.Add-ons and carve-outsConsolidate or separate platforms and unify reporting after a deal.Exit readinessFind the technology and data issues a buyer's diligence would raise, before it does.

Send DevriX a short brief

A short form on devrix.com. No call to book.

Disclosure: PE Firm Index is maintained by Mario Peshev, who founded and runs DevriX. DevriX listing

Weekly PE M&A and market research, by email

The Growth Shuttle Insider is Mario Peshev's weekly newsletter for PE owners and operators. Each issue carries the week's private equity deals from this index, market data and research, and an essay from Mario.

Free. One email a week. Unsubscribe from any issue. Your address goes to beehiiv, the service that sends the Insider.

Research

The 2027 Digital Value Creation Baseline

1,407 PE-backed companies from 179 sponsors, measured from public sources in October 2026. 15% of service and product companies have the full path from search to CRM.

Read the research

Research by Growth Shuttle and DevriX.